Mar 9, 2026
Podcast Host and Interviewee: Shahad Abdulsahib, PhD Candidate, UT Health San Antonio
Podcast Description:
Shahad Abdulsahib discusses a recent Phase 1 clinical trial on
Rhenium-186 nanoliposome therapy for recurrent glioma, published
in
Nature Communications
in March...
Mar 6, 2026
Dr. Alex Landry interviews Dr. Gelareh Zadeh on her career in academic neurosurgical oncology, focusing on the role of mentorship, how the field has evolved over time, and advice for junior trainees entering the field.
Mar 2, 2026
Dr. Maya Graham interviews Dr. Lauren Schaff on her manuscript entitled “Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL),” published in Neuro-Oncology in January 2026.
Feb 27, 2026
Dr. Nathan Dalton interviews Dr. Joseph Sia on the topic of radiation hypofractionation – its history, current clinical landscape, and potential future developments for patients with gliomas.
Feb 23, 2026
Shahad Abdulsahib discusses the findings of a recent paper, entitled “Transcriptional regulation of protein synthesis by mediator kinase represents a therapeutic vulnerability in MYC-driven medulloblastoma”, which was published in Nature Communications in...